Atlas Trials

A Prospective Study: the Impact of Sleep Disturbances on Immunotherapy in Patients With Lung Cancer

Clinical trial NCT06953765 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06953765
Sponsor
Shanghai Zhongshan Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Lung Cancer (NSCLC)Sleep Disorders, Circadian RhythmPD-1
Start date
2025-06-01
Primary completion
2028-12-30
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.